These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11890460)

  • 1. The use of quantitative histological and molecular data for risk assessment and biologically based model development.
    Andersen ME
    Toxicol Pathol; 2002; 30(1):106-11. PubMed ID: 11890460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
    Conolly RB; Andersen ME
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative selection in hepatic tumor promotion in relation to cancer risk assessment.
    Andersen ME; Mills JJ; Jirtle RL; Greenlee WF
    Toxicology; 1995 Sep; 102(1-2):223-37. PubMed ID: 7482557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic risks of dioxin: mechanistic considerations.
    Schwarz M; Appel KE
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):19-34. PubMed ID: 16054739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical mechanisms and cancer risk assessment models for dioxin.
    Kohn MC
    Toxicology; 1995 Sep; 102(1-2):133-8. PubMed ID: 7482548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promoters as inhibitors of apoptosis in rat hepatocytes.
    Schrenk D; Schmitz HJ; Bohnenberger S; Wagner B; Wörner W
    Toxicol Lett; 2004 Apr; 149(1-3):43-50. PubMed ID: 15093247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
    Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
    Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR.
    Connor KT; Aylward LL
    J Toxicol Environ Health B Crit Rev; 2006; 9(2):147-71. PubMed ID: 16613807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated cancer risk of dioxins to humans using a bioassay and physiologically based pharmacokinetic model.
    Maruyama W; Aoki Y
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):188-98. PubMed ID: 16443251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice.
    Beebe LE; Fornwald LW; Diwan BA; Anver MR; Anderson LM
    Cancer Res; 1995 Nov; 55(21):4875-80. PubMed ID: 7585523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
    Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
    Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.